The corticosterone-enhancing effects of the 5-HT 1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT 1A receptor

By Groenink L.   Van der Gugten J.   Mos J.   Maes R.A.A.   Oliver B.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

In vivo intrinsic efficacy of the 5-HT 1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors

By Ahlenius S.   Henriksson I.   Magnusson O.   Salmi P.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT 1A receptor agonist, using a behavioural model in rats

By Vis P.   Della Pasqua O.   Kruk M.   Martin D.   Mocaer E.   Danhof M.   Jochemsen R.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 233-243

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT 1A receptor agonist flesinoxan

By Zuideveld K.P.   van Gestel A.   Peletier L.A.   Van der Graaf P.H.   Danhof M.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 43-54

Elsevier

Access to resources Recommend Favorite

Behavorial Responses to the 5-HT1A Receptor Antagonist NAN190 Injected into Rat CA1 Hippocampal Area

By Belcheva I.   Belcheva S.   Petkov V.V.   Hadjiivanova C.   Petkov V.D.  

General Pharmacology, Vol. 28, Iss. 3, 1997-03 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite